Combined sleep deprivation and light therapy for depression in major depressive disorder and bipolar disorder
Abstract
Background. Combined chronotherapy, a combination of sleep deprivation and light therapy, offers a promising approach to accelerating improvement in depression. Therapeutic sleep deprivation can have a rapid antidepressant effect, while light therapy and regulation of sleep timing are intended to maintain the initial benefit. This review examines the evidence supporting further clinical evaluation of combined chronotherapy in major depressive disorder (MDD) and bipolar disorder (BD). Methods. We examined literature identified through PubMed/MEDLINE, Embase, Europe PMC and citation searching, with the latest search conducted on 9 September 2026. Narrative synthesis was used to examine speed and persistence of response, clinical applicability and tolerability. Controlled studies of combined chronotherapy, studies of individual treatment components and observational studies were considered separately, with repeated reports linked where identifiable. We interpreted outcomes in relation to treatment schedules, comparators and study limitations. Results. Seven randomised trials in adult patients with a depressive episode evaluated early antidepressant effects of combined chronotherapy. Several trials found rapid improvement, with benefits extending into follow-up, and outpatient studies support feasibility beyond inpatient settings. The most recent trial, including 44 randomised adults with masked outcome assessment, found greater improvement from day 5 through day 12 and discharge. Findings were not consistent across studies: one trial found an advantage confined to the first week, while two found no significant benefit on their primary comparisons. Studies of individual treatment components and clinical cohorts provide additional evidence on maintenance, patient selection and delivery. Conclusions. Combined chronotherapy is a promising adjunctive treatment for depression in MDD and BD, with evidence of rapid improvement and persistence of benefit in some trials. Findings vary across treatment protocols and settings, and the magnitude and durability of benefit remain uncertain. Further adequately powered randomised trials are needed to establish its clinical role.
Related
- Altered Inhibitory Control Across Subclinical Depression and Major Depressive Disorder: Evidence From Stroop Tasks and Diffusion Modeling.
- Effect of Long-Term Physical Exercise on Memory, Anxiety-Like Behavior, and Depression in Young and Aged Male Mice Subjected to Sleep Deprivation.
- Network-level convergence of functional and structural alterations in first-episode major depressive disorder
- Neurobiological mechanisms and brain network dysfunction in major depressive disorder: an integrative review
- Whole brain modeling reveals subtype specific regulation for adolescent major depressive disorder
BibTeX
@misc{haarman2026combined,
title = {{Combined sleep deprivation and light therapy for depression in major depressive disorder and bipolar disorder}},
author = {Bartholomeus Haarman and Stella Druiven and Jeanine Kamphuis},
howpublished = {PsyArXiv},
year = {2026},
month = sep,
doi = {10.31234/osf.io/d7bc2_v1},
url = {https://osf.io/preprints/psyarxiv/d7bc2_v1/},
note = {CC BY 4.0},
}
RIS
TY - UNPB
TI - Combined sleep deprivation and light therapy for depression in major depressive disorder and bipolar disorder
AU - Bartholomeus Haarman
AU - Stella Druiven
AU - Jeanine Kamphuis
PY - 2026
DA - 2026/09/11
PB - PsyArXiv
DO - 10.31234/osf.io/d7bc2_v1
UR - https://osf.io/preprints/psyarxiv/d7bc2_v1/
AB - Background. Combined chronotherapy, a combination of sleep deprivation and light therapy, offers a promising approach to accelerating improvement in depression. Therapeutic sleep deprivation can have a rapid antidepressant effect, while light therapy and regulation of sleep timing are intended to maintain the initial benefit. This review examines the evidence supporting further clinical evaluation of combined chronotherapy in major depressive disorder (MDD) and bipolar disorder (BD). Methods. We examined literature identified through PubMed/MEDLINE, Embase, Europe PMC and citation searching, with the latest search conducted on 9 September 2026. Narrative synthesis was used to examine speed and persistence of response, clinical applicability and tolerability. Controlled studies of combined chronotherapy, studies of individual treatment components and observational studies were considered separately, with repeated reports linked where identifiable. We interpreted outcomes in relation to treatment schedules, comparators and study limitations. Results. Seven randomised trials in adult patients with a depressive episode evaluated early antidepressant effects of combined chronotherapy. Several trials found rapid improvement, with benefits extending into follow-up, and outpatient studies support feasibility beyond inpatient settings. The most recent trial, including 44 randomised adults with masked outcome assessment, found greater improvement from day 5 through day 12 and discharge. Findings were not consistent across studies: one trial found an advantage confined to the first week, while two found no significant benefit on their primary comparisons. Studies of individual treatment components and clinical cohorts provide additional evidence on maintenance, patient selection and delivery. Conclusions. Combined chronotherapy is a promising adjunctive treatment for depression in MDD and BD, with evidence of rapid improvement and persistence of benefit in some trials. Findings vary across treatment protocols and settings, and the magnitude and durability of benefit remain uncertain. Further adequately powered randomised trials are needed to establish its clinical role.
ER -